Psychiatrie
+I5@=HQHG69F=7<H�� ��B57<�89F�0CF@5;9�JCB�"�
F9=;569�5A��IF7<� 09FG=CB
Clienia-Privatklinikgruppe
www.clienia.ch
Impressum�=9G9F�+I5@=HQHG69F=7<H�KIF89�B57<�89F�0CF@5;9�JCB�"���=9�-D=HQ@9F�89F�-7<K9=N�9FGH9@@H���=9�0CF@5;989G�+I5@=HQHG69F=7<HG�8=9BH�89F�9=B<9=H@=7<9B��9F=7<H9FGH5HHIB;�:TF�8=9�%5H9;CF=9B��?IHGCA5H=?*GM7<=5HF=9�IB8�,9<56=@=H5H=CB�:TF�85G��9F=7<HG>5<F�� ���
�9F�+I5@=HQHG69F=7<H�9FAS;@=7<H�9=B9B�GMGH9A5H=G7<9B�P69F6@=7?�T69F�8=9�+I5@=HQHG5F69=H9B�9=B9G-D=H5@G�C89F�9=B9F�%@=B=?�=B�89F�-7<K9=N���=9G9F�P69F6@=7?�N9=;H�89B��I:65I�89G�=BH9FB9B+I5@=HQHGA5B5;9A9BHG�GCK=9�8=9�T69F;9CF8B9H9B�+I5@=HQHGN=9@9�5I:�IB8�69=B<5@H9H��B;569B�NI�9:F5;IB;9B�'9GG69H9=@=;IB;9B�,9;=GH9FH9=@B5<A9B�IB8�39FH=:=?5H9B�� 9FB9F�K9F89B+I5@=HQHG=B8=?5HCF9B�IB8�'5GGB5<A9B�*FC;F5AA9�GCK=9�*FC>9?H9�NIF�+I5@=HQHGG=7<9FIB;�56;9:F5;H�
/A�8=9��F;96B=GG9�89F�+I5@=HQHGA9GGIB;�F=7<H=;�NI�=BH9FDF9H=9F9B�IB8�J9F;@9=7<9B�NI�?SBB9B�8TF:9B8=9��B;569B�NIA��B;96CH�89F�9=BN9@B9B�%@=B=?9B�B=7<H�5IGG9F��7<H�;9@5GG9B�K9F89B��3I89A�AIGG89B�/BH9FG7<=989B�IB8�09FQB89FIB;9B�=B�89F�*5H=9BH9BGHFI?HIF�IB8�69=�89B�,=G=?C:5?HCF9B�,97<BIB;;9HF5;9B�K9F89B�
Zielpublikum
�9F�+I5@=HQHG69F=7<H�F=7<H9H�G=7<�5B� 57<D9FGCB9B�5IG�89A�!9GIB8<9=HGK9G9B��-D=H5@A5B5;9A9BHIB8�'=H5F69=H9F�5IG�89A�!9GIB8<9=HGK9G9B�89F�!9GIB8<9=HG?CAA=GG=CB9B�IB8�89F!9GIB8<9=HGDC@=H=?�GCK=9�89F�09FG=7<9F9F��IB8�8=9�=BH9F9GG=9FH9�O::9BH@=7<?9=H�
Kontaktperson Qualit�tsbericht 2015
F5I-IG5BB9�1MGG09F5BHKCFH@=7<9�)F;5B=G5H=CBG9BHK=7?@IB; ���������� �GIG5BB9�KMGG�7@=9B=5�7<
+I5@=HQHG69F=7<H�� �� Impressum
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9���JCB���
Vorwort von H+ Die Spit�ler der Schweiz�=9�-D=HQ@9F�IB8�%@=B=?9B�=B�89F�-7<K9=N�<569B�9=B�<C<9G�+I5@=HQHG69KIGGHG9=B��(96GH�89F�IF7<:T<FIB;�JCB�N5<@F9=7<9B�=BH9FB9B�+I5@=HQHG5?H=J=HQH9B�B9<A9B�G=9�5B�A9<F9F9B�B5H=CB5@9B�IB8H9=@K9=G9�?5BHCB5@9B�'9GGIB;9B�H9=@��!9AQGG�89A�'9GGD@5B�89G�(5H=CB5@9B�09F9=BG�:TF+I5@=HQHG9BHK=7?@IB;�=B�-D=HQ@9FB�IB8�%@=B=?9B���(+��:=B89B�'9GGIB;9B�=B�89B�GH5H=CBQF9B��9F9=7<9B89F��?IHGCA5H=?�*GM7<=5HF=9�IB8�,9<56=@=H5H=CB�GH5HH��#A��9F=7<HG>5<F�� ���KIF89B�?9=B9�B9I9BB5H=CB5@9B�'9GGIB;9B�9=B;9:T<FH�
�=9�-=7<9F<9=H�:TF�*5H=9BH=BB9B�IB8�*5H=9BH9B�=GH�9=B�K9G9BH@=7<9G�%F=H9F=IA�89F��9<5B8@IB;GEI5@=HQH��B89�'QFN�� ���GH5FH9H9�85G�B5H=CB5@9�09FH=9:IB;GDFC>9?H�DFC;F9GG��-=7<9F9�'98=?5H=CB�5B-7<B=HHGH9@@9B�89F�-H=:HIB;�*5H=9BH9BG=7<9F<9=H�-7<K9=N���5G�*FC>9?H�:C?IGG=9FH�5I:�89B�GMGH9A5H=G7<9B'98=?5H=CBG56;@9=7<�69=�-D=H5@9=BHF=HH��#A�-CAA9F�?CBBH9�8=9�-H=:HIB;�85G�9FGH9�*=@CHDFC;F5AADFC;F9GG��-=7<9F9��<=FIF;=9�9F:C@;F9=7<�56G7<@=9GG9B��3=9@�K5F�85GG�8=9�-D=HQ@9F�IB8�%@=B=?9B�8=97<=FIF;=G7<9��<97?@=GH9�69=�>989F�)D9F5H=CB�?CFF9?H�5BK9B89B�IA�-7<Q89B�5B�*5H=9BH9B�NIJ9FA9=89B��#A�-9DH9A69F�:T<FH9�*5H=9BH9BG=7<9F<9=H�-7<K9=N�9FGHA5@G�9=B9��?H=CBGKC7<9�IBH9F�89A'CHHC��U'=H�*5H=9BH=BB9B�IB8�*5H=9BH9B�=A��=5@C;V�8IF7<��35<@F9=7<9�-D=HQ@9F�IB8�%@=B=?9B�69H9=@=;9BG=7<�969B:5@@G�
#A�!9GIB8<9=HGK9G9B�G=B8�.F5BGD5F9BN�IB8�09F;@9=7<65F?9=H�K9G9BH@=7<9�!FIB8@5;9B�:TF�9=B9-H9=;9FIB;�89F�+I5@=HQH���IG�8=9G9A�!FIB8�GH9@@H�"��G9=B9B�'=H;@=989FB�>Q<F@=7<�9=B9�0CF@5;9�NIF+I5@=HQHG69F=7<H9FGH5HHIB;�NIF�09F:T;IB;�
�=9�=B�8=9G9F�0CF@5;9�DI6@=N=9FH9B��F;96B=GG9�89F�+I5@=HQHGA9GGIB;9B�69N=9<9B�G=7<�5I:�8=9�9=BN9@B9B-D=HQ@9F�IB8�%@=B=?9B���9=A�09F;@9=7<9B�89F�'9GG9F;96B=GG9�NK=G7<9B�89B��9HF=969B�G=B8�;9K=GG9%F=H9F=9B�NI�69FT7?G=7<H=;9B���=B9FG9=HG�GC@@H9�85G�&9=GHIB;G5B;96CH��J;@���B<5B;����Q<B@=7<�G9=B���=B9*F=J5H?@=B=?�N����69<5B89@H�5B89F9� Q@@9�5@G�9=B�/B=J9FG=HQHGGD=H5@�K9G<5@6�5I7<�89F9B'9GG9F;96B=GG9�IBH9FG7<=98@=7<�NI�K9FH9B�G=B8��3I89A�J9FK9B89B�8=9�-D=HQ@9F�IB8�%@=B=?9BJ9FG7<=989B9�'9H<C89���#BGHFIA9BH9�89F9B�-HFI?HIF��I:65I��F<96IB;�IB8�*I6@=?5H=CB�G=7<IBH9FG7<9=89B�?SBB9B��*IB?HI9@@9�09F;@9=7<9�G=B8�69=�B5H=CB5@�9=B<9=H@=7<9B�'9GGIB;9B�AS;@=7<89F9B��F;96B=GG9�DFC�%@=B=?�IB8�-D=H5@�F9GD��DFC�-D=H5@GH5B8CFH�58>IGH=9FH�K9F89B��19=H9F9#B:CFA5H=CB9B�85NI�:=B89B�-=9�=B�89B�/BH9F?5D=H9@B�=B�8=9G9A��9F=7<H�IB8�5I: KKK�5BE�7<�
F9IB8@=7<9�!FTGG9
�F���9FB<5F8�19;AT@@9F�=F9?HCF�"�
+I5@=HQHG69F=7<H�� �� Vorwort von H+ Die Spit�ler der Schweiz
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9���JCB���
Inhaltsverzeichnis
Impressum ............................................................................................................................................. 2
Vorwort von H+ Die Spit�ler der Schweiz ........................................................................................... 3
Einleitung............................................................................................................................... 51
Organisation des Qualit�tsmanagements .......................................................................... 62)F;5B=;F5AA �������������������������������������������������������������������������������������������������������������������������� ����%CBH5?HD9FGCB9B�5IG�89A�+I5@=HQHGA5B5;9A9BH ����������������������������������������������������������������������
Qualit�tsstrategie.................................................................................................................. 733K9=�6=G�8F9=�+I5@=HQHGG7<K9FDIB?H9�=A��9F=7<HG>5<F�� ������������������������������������������������������������FF9=7<H9�+I5@=HQHGN=9@9�=A��9F=7<HG>5<F�� �� ������������������������������������������������������������������������� ����+I5@=HQHG9BHK=7?@IB;�=B�89B�?CAA9B89B�$5<F9B������������������������������������������������������������������������
�berblick �ber s�mtliche Qualit�tsaktivit�ten ...................................................................94.9=@B5<A9�5B�B5H=CB5@9B�'9GGIB;9B ������������������������������������������������������������������������������������� �����IF7<:T<FIB;�JCB�?5BHCB5@�JCF;9;969B9B�'9GGIB;9B ��������������������������������������������������������������IF7<:T<FIB;�JCB�NIGQHN@=7<9B�GD=H5@�IB8�?@=B=?9=;9B9B�'9GGIB;9B����������������������������������� ���+I5@=HQHG5?H=J=HQH9B�IB8�DFC>9?H9������������������������������������������������������������������������������������������ ������#,-�X�&9FB9B�5IG�3K=G7<9B:Q@@9B��������������������������������������������������������������������������������������� �������39FH=:=N=9FIB;GT69FG=7<H ��������������������������������������������������������������������������������������������������������� �����
QUALIT�TSMESSUNGEN................................................................................................................... 14
Befragungen ........................................................................................................................................ 15
Patientenzufriedenheit........................................................................................................ 155�=;9B9��9:F5;IB; ����������������������������������������������������������������������������������������������������������������� �����3T*5N�IB8�'TD:�������������������������������������������������������������������������������������������������������������������� ��������9G7<K9F89A5B5;9A9BH ����������������������������������������������������������������������������������������������������� �����
Mitarbeiterzufriedenheit ..................................................................................................... 166�=;9B9��9:F5;IB; ����������������������������������������������������������������������������������������������������������������� �����=7CAA=H���������������������������������������������������������������������������������������������������������������������������������� �������
Zuweiserzufriedenheit ........................................................................................................ 177�=;9B9��9:F5;IB; ����������������������������������������������������������������������������������������������������������������� ������=;9B9��9:F5;IB; ����������������������������������������������������������������������������������������������������������������� �������
Behandlungsqualit�t ........................................................................................................................... 18
Freiheitsbeschr�nkende Massnahmen ............................................................................. 188(5H=CB5@9��F:5GGIB;�89F�:F9=<9=HG69G7<FQB?9B89B�'5GGB5<A9B�=B�89F�FK57<G9B9BDGM7<=5HF=9�IB8�%=B89F�IB8�$I;9B8DGM7<=5HF=9�������������������������������������������������
���
Psychische Symptombelastung ........................................................................................ 199(5H=CB5@9�'9GGIB;�=B�89F��FK57<G9B9BDGM7<=5HF=9 ������������������������������������������������������������������(5H=CB5@9�'9GGIB;�=B�89F�%=B89F�IB8�$I;9B8DGM7<=5HF=9����������������������������������������������������� ���
Projekte im Detail ................................................................................................................ 2110�?HI9@@9�+I5@=HQHGDFC>9?H9 ����������������������������������������������������������������������������������������������������� ��� ���#,-��I8=H ���������������������������������������������������������������������������������������������������������������������������� ��� �����6;9G7<@CGG9B9�+I5@=HQHGDFC>9?H9�=A��9F=7<HG>5<F�� �� ��������������������������������������������������������� ���=J9FG9G �������������������������������������������������������������������������������������������������������������������������������� ��� �����?HI9@@9�39FH=:=N=9FIB;GDFC>9?H9 ��������������������������������������������������������������������������������������������� ��� �� F9A85GG9GGA9BH�,���%@=B=?�-7<@SGG@=�IB8�&=HH9B<9=8 ����������������������������������������������������������� ����
Schlusswort und Ausblick ................................................................................................. 2211
Anhang 1: �berblick �ber das betriebliche Angebot....................................................................... 23*GM7<=5HF=9 ��������������������������������������������������������������������������������������������������������������������������������������������� ��
Herausgeber ........................................................................................................................................ 24
+I5@=HQHG69F=7<H�� ��
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9���JCB���
Einleitung1�=9G9F��9F=7<H�N9=;H�8=9��?H=J=HQH9B�89F�;9G5AH9B��@=9B=5*F=J5H?@=B=?;FIDD9�5I:�� C@;9B89�-H5B8CFH9G=B8�=BH9;F=9FH�
�@=9B=5�-7<@SGG@=��!�A=H�89F�%@=B=?�-7<@SGG@=�*GM7<=5HF=9N9BHFIA�19HN=?CB���/GH9F�IB8*GM7<=5HF=9N9BHFIA�'QBB98CF:�@=9B=5�&=HH9B<9=8��!�A=H�89F�%@=B=?�&=HH9B<9=8�*GM7<=5HF=9N9BHFIA� F5I9B:9@8�IB8�*GM7<=5HF=9N9BHFIA-=FB57<�@=9B=5��9F;<9=A��! �&5B;N9=H=BGH=HIH=CB��@=9B=5�!FIDD9BDF5L9B��!�A=H�!FIDD9BDF5L9B�=B�1=BH9FH<IF�)9F@=?CB�IB8��=9H=?CB
�9H5=@@=9FH9�#B:CFA5H=CB9B�NIA�&9=GHIB;G5B;96CH�:=B89B�-=9�=A �B<5B;���
+I5@=HQHG69F=7<H�� �� Einleitung
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9���JCB���
F5I�-IG5B5B9�1MGG09F5BHKCFH@=7<9�)F;5B=G5H=CBG9BHK=7?@IB;�@=9B=5*F=J5H?@=B=?;FIDD9 ���������� �GIG5BB9�KMGG�7@=9B=5�7<
"9FF�-H9D<5B� F9=&9=H9F�*FC>9?H9�IB8��BHK=7?@IB;�@=9B=5*F=J5H?@=B=?;FIDD9 ������������GH9D<5B�:F9=�7@=9B=5�7<
F5I��@G69H<��9HG7<CB09F5BHKCFH@=7<9�+I5@=HQHGA5B5;9A9BH�@=9B=5*F=J5H?@=B=?;FIDD9 ����������� 9@G69H<�69HG7<CB�7@=9B=5�7<
Organisation des Qualit�tsmanagements2
Organigramm2.1
�5G�+I5@=HQHGA5B5;9A9BH�=GH�5@G�-H56G:IB?H=CB�8=F9?H�89F�!9G7<Q:HG@9=HIB;�IBH9FGH9@@H�
TF�85G�+I5@=HQHGA5B5;9A9BH�GH9<9B�=BG;9G5AH 470 -H9@@9BDFCN9BH9�NIF�09F:T;IB;�
Bemerkungen�=9�-H9@@9BDFCN9BH9�69N=9<9B�G=7<�5I:�8=9�F9=B9B�-HQ69��+I5@=HQHGA5B5;9A9BH:IB?H=CB9B�G=B8�569F5I7<�=B�89F�&=B=9�5@@9F�-H5B8CFH9�5B;9G=989@H�
Kontaktpersonen aus dem Qualit�tsmanagement2.2
+I5@=HQHG69F=7<H�� �� Organisation des Qualit�tsmanagements
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9���JCB���
Qualit�tsstrategie3�5G�+I5@=HQHGA5B5;9A9BH�K=F8�5@G�.9=@�89F�)F;5B=G5H=CBG9BHK=7?@IB;�J9FGH5B89B�IB8�=B�89F��@=B=5*F=J5H?@=B=?;FIDD9�6F9=H�;9@96H�=B89A�9G�GQAH@=7<9�BCFA5H=J9B�GHF5H9;=G7<9B�IB8�CD9F5H=J9B'5GGB5<A9B�69=B<5@H9H�IA�8=9�)F;5B=G5H=CB�:Q<=;�NI�;9GH5@H9B�IB8�:@9L=69@�IB8�DFC:9GG=CB9@@�5I:09FQB89FIB;9B�=A�F9@9J5BH9B�/A:9@8�NI�F95;=9F9B��+I5@=HQHG�IB8�)F;5B=G5H=CBG9BHK=7?@IB;�69HF9::9BGQAH@=7<9� T<FIB;G969B9B�IB8�K9F89B�H5;HQ;@=7<�=A� T<FIB;G�IB8��F69=HG5@@H5;�;9@96H��$989F9=BN9@B9�'=H5F69=H9B89�89F��@=9B=5�HFQ;H�=A�,5<A9B�G9=B9F� IB?H=CB�NIF�+I5@=HQHGGH9=;9FIB;�IB8�GCA=HNIF �BHK=7?@IB;�89G�/BH9FB9<A9BG�69=��$989� T<FIB;GD9FGCB�HFQ;H�8=9�09F5BHKCFHIB;�:TF�8=919=H9F9BHK=7?@IB;�
�=9�)F;5B=G5H=CBG9BHK=7?@IB;�IB8�85G�+I5@=HQHGA5B5;9A9BH�<569B B57<GH9<9B89�0=G=CB�'=GG=CBIB8�!FIB8GQHN9�K9@7<9�GQAH@=7<9��?H=J=HQH9B�@9=H9B���@@9G�KIF89�JCB�89F�T69F;F9=:9B89B�0=G=CB'=GG=CB�IB8�&9=H6=@8�89F�!FIDD9�56;9@9=H9H�IB8�GHF5H9;=G7<�56;9GHTHNH�
���)��0=G=CB�=9��@=9B=5*F=J5H?@=B=?;FIDD9[�9F:T@@H�C89F�T69FHF=::H�8=9��FK5FHIB;9B�89F�#BH9F9GG9B;FIDD9B[�9FN=9@H�@5B;:F=GH=;�;IH9��F;96B=GG9[�;9<H�GHF5H9;=9CF=9BH=9FH�IB8�56;9GH=AAH�JCF�IB8�G9HNH�?CBG9EI9BH�IA[�=GH�G7<K9=NK9=H�:T<F9B8�=B�*GM7<=5HF=9�IB8�*GM7<CH<9F5D=9
���)��'=GG=CB[�1=F�IBH9FGHTHN9B�IBG�;9;9BG9=H=;�69=�89F��F:T@@IB;�89F��98TF:B=GG9�IBG9F9F�#BH9F9GG9BG;FIDD9B�*5H=9BH9B�'=H5F69=H9B89�*5FHB9F��IB8�69=�89F��FF9=7<IB;�89F�IBH9FB9<A9F=G7<9B�3=9@9[�1=F�9BHK=7?9@B�IBG9F9�)F;5B=G5H=CB�GMGH9A5H=G7<�IB8�?CBH=BI=9F@=7<�K9=H9F[�1=F�D:@9;9B�IB8�@969B�9=B�G7<@5B?9G�'5B5;9A9BHGMGH9A�IB8�9=B�F9=:9G�*FCN9GGA5B5;9A9BH
���!FIB8GQHN9[�+I5@=HQH�5@G��9GH5B8H9=@�89F�)F;5B=G5H=CBG9BHK=7?@IB;�69HF=::H�IBG�5@@9[�1=F�D:@9;9B�=B�IBG9F9A��F69=HG5@@H5;�8=9�?CBH=BI=9F@=7<9�09F69GG9FIB;[�1=F�CF=9BH=9F9B�IBG�5A�� +'�'C89@@�5@G�T69F;9CF8B9H9G�'C89@@[�1=F�F98IN=9F9B�09FG7<K9B8IB;9B[�1=F�@9FB9B�8IF7<�5?H=J9G��9B7<A5F?=B;
���-HF5H9;=G7<9��IGG5;9B[��I:65I�9=B9G�;9A9=BG5A9B�'5B5;9A9BHGMGH9AG[�09F69GG9FIB;GDFCN9GG9�5@G�-9@6GHJ9FGHQB8@=7<?9=H�=A��@@H5;�9FAS;@=7<9B�IB8�=BH9;F=9F9B[��I:65I�IB8�(IHN9B�JCB�GHF5H9;=G7<9B�*5FHB9FG7<5:H9B�IB8�F9@9J5BH9B�(9HNK9F?9�NIA�09F;@9=7<9BIB8�&9FB9B[�-7<5::9B�9=B9G�=BH9FB9B�)�-IDDCFH�%CAD9H9BNN9BHFIAG[�%CBG9EI9BH9G�(IHN9B�JCB�-MB9F;=9B�=BB9F<5@6�89F�!FIDD9��%CAD9H9BN9B�1=GG9B�IGK���
�=9�+I5@=HQH�=GH�=B�89F�/BH9FB9<A9BGGHF5H9;=9�F9GD��=B�89B�/BH9FB9<A9BGN=9@9B�9LD@=N=H�J9F5B?9FH�
Zwei bis drei Qualit�tsschwerpunkte im Berichtsjahr 20153.1
] �=B:T<FIB;�IB8��IGFC@@9B�JCB�&95BA5B5;9A9BH] 09F9=B<9=H@=7<IB;�89F�*FCN9GG@5B8?5FH9�IB8��9:=B=H=CB�JCB�;FIDD9BK9=H9B�*FCN9GG9B] �=B:T<FIB;�9=B9F�B9I9B�-HFI?HIF�89G�*FC>9?HA5B5;9A9BHG
+I5@=HQHG69F=7<H�� �� Qualit�tsstrategie
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9���JCB���
Erreichte Qualit�tsziele im Berichtsjahr 20153.2
] �5G�&95BA5B5;9A9BH�=GH�5B�89B�-H5B8CFH9B�&=HH9B<9=8�IB8�-7<@SGG@=�9H56@=9FH�IB8�KIF89�=A� ���BC7<�69GG9F�69=�5@@9B�'=H5F69=H9B89B�J9F5B?9FH��#A��9F;<9=A�IB8�=B�89B�!FIDD9BDF5L9BKIF89B�;9K=GG9�0CF;9<9BGK9=G9B�9=B;9:T<FH�ATGG9B�569F�=A�� ���K9=H9F�J9FH=9:H�IB85IG;9FC@@H�K9F89B�
] �=9�*FCN9GG@5B8?5FH9�KIF89�T69F�8=9�;9G5AH9�!FIDD9�J9F9=B<9=H@=7<H�IB8�9BHGDF=7<H�89A�����#�89F��@=9B=5���I7<�KIF89B�69F9=HG�;9K=GG9�*FCN9GG9�5I:�!FIDD9B969B9�89:=B=9FH�IB8�5B5@@9B�-H5B8CFH9B�J9F@=B?H�
] �=9�0CF;9<9BGK9=G9�69=�09FQB89FIB;9B�KIF89�;FIB8@9;9B8�T69F5F69=H9H�IB8�;FIDD9BK9=HJ9F9=B<9=H@=7<H��-QAH@=7<9��?H=J=HQH9B�K9F89B�5B<5B8�JCB�8F9=�0CF;9<9BGK9=G9B��*FC>9?H9&95B.<9A9B�+I=7?1=BG� 56;9<5B89@H�K9@7<9�5B<5B8�89F�GHF5H9;=G7<9B��989IHIB;�IB8�89G�I:K5B89G�HF=5;=9FH�K9F89B�
19=H9F9��B;569B�:=B89B�-=9�=A�$5<F9G69F=7<H�� ���
Qualit�tsentwicklung in den kommenden Jahren3.3
���19=H9F9G��IGFC@@9B�IB8��H56@=9F9B�JCB�&95BA5B5;9A9BH�=B�89F�;9G5AH9B�!FIDD9����5G�*FCN9GGA5B5;9A9BH�K9=H9F�:SF89FB�IB8�9=B9B�<S<9F9B�,9=:9;F58�9FF9=7<9B���� +'�K9=H9F�=BB9F<5@6�89F�!FIDD9�J9F5B?9FB�8IF7<�=BH9FB9��GG9GGA9BHG�IB8�NK9= F9A85GG9GGA9BHG�5B�89B�-H5B8CFH9B�&=HH9B<9=8�IB8�-7<@SGG@=�
+I5@=HQHG69F=7<H�� �� Qualit�tsstrategie
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9���JCB���
�b
erb
lick �
ber
s�m
tlic
he Q
ualit�
tsakti
vit
�te
n4
Teiln
ah
me a
n n
ati
on
ale
n M
essu
ng
en
4.1
#A�(5H=CB5@9B�09F9=B�:TF�+I5@=HQHG9BHK=7?@IB;�=B�-D=HQ@9F�IB8�%@=B=?9B���(+��G=B8�89F�-D=H5@J9F65B8�"��8=9�%5BHCB9�8=9�!9GIB8<9=HG8=F9?HCF9B?CB:9F9BN
!�%�89F�09F65B8�89F�%F5B?9B?5GG9B�G5BHRGI=GG9�IB8�8=9�9=8;9BSGG=G7<9B�-CN=5@J9FG=7<9F9F�J9FHF9H9B��3K97?�89G��(+�=GH�8=9�%CCF8=B5H=CB�89F
9=B<9=H@=7<9B�/AG9HNIB;�JCB��F;96B=GEI5@=HQHG'9GGIB;9B�=B�-D=HQ@9FB�IB8�%@=B=?9B�A=H�89A�3=9@�8=9�+I5@=HQH�NI�8C?IA9BH=9F9B�K9=H9FNI9BHK=7?9@B�IB8�NI
J9F69GG9FB���=9�'9H<C89B�89F��IF7<:T<FIB;�IB8�89F��IGK9FHIB;�G=B8�:TF�5@@9��9HF=969�>9K9=@G�8=9G9@69B�
19=H9F9�#B:CFA5H=CB9B�:=B89B�-=9�DFC�+I5@=HQHGA9GGIB;�>9K9=@G�=B�89B�/BH9F?5D=H9@B�\(5H=CB5@9��9:F5;IB;9BY�6NK��\(5H=CB5@9�'9GGIB;9BY�IB8�5I:�89F
196G9=H9�89G��(+KKK�5BE�7<�
Un
ser
Betr
ieb
hat
im B
eri
ch
tsja
hr
wie
fo
lgt
am
nati
on
ale
n M
essp
lan
teilg
en
om
men
:
Psychiatrie
]�FK57<G9B9BDGM7<=5HF=9
X-MA
DHCA69@5GHIB;�� F9A869K9FHIB;�
X-MA
DHCA69@5GHIB;��-9@6GH69K9FHIB;�
X�F<96IB;�89F�:F9=<9=HG69G7<FQB?9B89B�'5GGB5<A9B
]%=B89F�IB8�$I;9B8DGM7<=5HF=9
X-MA
DHCA69@5GHIB;�� F9A869K9FHIB;�
X-MA
DHCA69@5GHIB;��-9@6GH69K9FHIB;�
X�F<96IB;�89F�:F9=<9=HG69G7<FQB?9B89B�'5GGB5<A9B
Bem
erk
un
gen
�=9��@=9B=5�A=GGH�8=9�")()-�IB8��-�&�19FH9�IB8�K9FH9H�G=9F9;9@AQGG=;�5IG�C6KC<@�8=9�G7<K9=NK9=H9�,=G=?C58>IGH=9FIB;�9FGH�GDQH9F�8IF7<��(+
5IG;9:T<FH�K=F8���=9G9G�09F:5<F9B�9FAS;@=7<H�9=B�N9=HB5<9G��F;F9=:9B�5@@:Q@@=;9F�'5GGB5<A9B�
�B;569B�NI�89B�19FH9B�:=B89B�-=9�=A
�$5<F9G69F=7<H
Du
rch
f�h
run
g v
on
kan
ton
al vo
rgeg
eb
en
en
Messu
ng
en
4.2 U
nser
Betr
ieb
hat
im B
eri
ch
tsja
hr
folg
en
de k
an
ton
ale
n V
org
ab
en
um
gesetz
t u
nd
fo
lgen
de k
an
ton
al vo
rgeg
eb
en
en
Messu
ng
en
du
rch
gef�
hrt
:
]=A�%5BHCB�3TF=7<�3T*5N�IB8�'TD:���5A6���9F9=7<
+I5@=HQHG69F=7<H�� ��
�b
erb
lick �
ber
s�m
tlic
he Q
ualit�
tsakti
vit
�te
n
�@=9B=5*F=J5H?@=B=?;FIDD9
-9=H9���JCB���
Du
rch
f�h
run
g v
on
zu
s�tz
lich
en
sp
ital-
un
d k
lin
ikeig
en
en
Messu
ng
en
4.3
(969B�89B�B5H=CB5@�IB8�?5BHCB5@�JCF;9;969B9B�+I5@=HQHGA9GGIB;9B�<5H�IBG9F��9HF=96�NIGQHN@=7<9�+I5@=HQHGA9GGIB;9B�8IF7<;9:T<FH�
Un
ser
Betr
ieb
hat
folg
en
de s
pit
ale
igen
e B
efr
ag
un
gen
du
rch
gef�
hrt
:
Patientenzufriedenheit
]3T*5N�IB8�'TD:
Mitarbeiterzufriedenheit
]=7CAA=H
Zuweiserzufriedenheit
]�=;9B9��9:F5;IB;
Un
ser
Betr
ieb
hat
folg
en
de s
pit
ale
igen
e M
essu
ng
(en
) d
urc
hg
ef�
hrt
:
St�rze
],�#�,/!�BIF�:TF�85G��9F;<9=A
+I5@=HQHG69F=7<H�� ��
�b
erb
lick �
ber
s�m
tlic
he Q
ualit�
tsakti
vit
�te
n
�@=9B=5*F=J5H?@=B=?;FIDD9
-9=H9�� �JCB���
Qu
alit�
tsakti
vit
�te
n u
nd
-p
roje
kte
4.4
"=9F�:=B89B�-=9�9=B9��I:@=GHIB;�89F�D9FA5B9BH9B��?H=J=HQH9B�GCK=9�89F�@5I:9B89B�+I5@=HQHGDFC>9?H9�
&95B�'5B5;9A9BH
Zie
l,98I?H=CB�JCB�09FG7<K9B8IB;
Bere
ich
, in
dem
die
Akti
vit
�t
od
er
das P
roje
kt
l�u
ft!9G5AH9�!FIDD9
Pro
jekte
: L
au
fzeit�JCBW6=G�
Beg
r�n
du
ng
�9F�%CGH9B8FI7?�K=F8�=A
�!9GIB8<9=HGK9G9B�GHQF?9F���IF7<�9=B9�K9=H9F9��H56@=9FIB;�IB8��IG65I�89G
&95BA5B5;9A9BH�?SBB9B�8=9��F:5<FIB;9B�IB8�85G�1=GG9B�89F�69HFC::9B9B�'=H5F69=H9B89B�;9BIHNH�K9F89B
IA�09FG7<K9B8IB;9B�NI�F98IN=9F9B�IB8��9GH�*F57H=79�0CF;9<9BG
,9=:9�G7<@5B?9�*FCN9GG9
Zie
l*FC:9GG=CB9@@9G�*FCN9GGA5B5;9A9BH
Bere
ich
, in
dem
die
Akti
vit
�t
od
er
das P
roje
kt
l�u
ft!9G5AH9�!FIDD9
Pro
jekte
: L
au
fzeit�JCBW6=G�
Beg
r�n
du
ng
�IF7<�9=B9�K9=H9F9�09F9=B<9=H@=7<IB;�JCB�;FIDD9BK9=H9B�*FCN9GG9B�?SBB9B�-MB9F;=9B�;9BIHNH�K9F89B���=9
*:@9;9�IB8�09F69GG9FIB;�89F�*FCN9GG9�AIGG�B=7<H�5B�>989A�-H5B8CFH�9F6F57<H�K9F89B�GCB89FB�?5BB�8IF7<
9::=N=9BH9�*FCN9GGH95AG�T69FBCAA9B�K9F89B�
�IG=B9GG��L79@@9B79
Zie
l��2
Bere
ich
, in
dem
die
Akti
vit
�t
od
er
das P
roje
kt
l�u
ft!9G5AH9�!FIDD9
Pro
jekte
: L
au
fzeit�JCBW6=G�
Beg
r�n
du
ng
�IG=B9GG��L79@@9B79�GC@@�K9=H9F�5@G�,5<A9B�IBG9F9F��?H=J=HQH9B�;9BIHNH�K9F89B���5G�� +'�'C89@@�K=F8
=AA9F�K=989F�69=;9NC;9B��-C�8=9B9B�=BH9FB9��GG9GGA9BH�NIF��J5@I5H=CB�JCB�09F69GG9FIB;GDCH9BN=5@9B�IB8
89F�,���,�NIA�"=BH9F:F5;9B�89F�;QB;=;9B��?H=J=HQH9B�
Bem
erk
un
gen
+I5@=HQHG69F=7<H�� ��
�b
erb
lick �
ber
s�m
tlic
he Q
ualit�
tsakti
vit
�te
n
�@=9B=5*F=J5H?@=B=?;FIDD9
-9=H9����JCB���
�#,-�X�&9FB9B�5IG�3K=G7<9B:Q@@9B
�����
�#,-�=GH�9=B� 9<@9FA9@89GMGH9A�=B�K9@7<9A�'=H5F69=H9B89�?F=H=G7<9��F9=;B=GG9�C89F� 9<@9F�8=9�=A
��F69=HG5@@H5;�69=B5<9�NI�-7<Q89B�;9:T<FH�<QHH9B�9F:5GG9B
?SBB9B���I:�8=9G9�19=G9�<=@:H��#,-�-7<K57<GH9@@9B�=B�89F�)F;5B=G5H=CB�IB8�=B��F69=HG56@QI:9B�NI�9BH897?9B���#,-�GH9<H�:TF��F=H=75@�#B7=89BH�,9DCFH=B;
-MGH9A���I:;FIB8�89F��BH897?IB;9B�?SBB9B�G=7<9F<9=HGF9@9J5BH9�09F69GG9FIB;GA
5GGB5<A9B�9=B;9@9=H9H�K9F89B�
/BG9F��9HF=96�<5H�9=B��#,-�=A
�$5<F�� ���9=B;9:T<FH�
�5G�0CF;9<9B�:TF�8=9��=B@9=HIB;�IB8�/AG9HNIB;�JCB�09F69GG9FIB;GA
5GGB5<A9B�=GH�89:=B=9FH�
�BHGDF97<9B89�-HFI?HIF9B�!F9A=9B�IB8�09F5BHKCFH@=7<?9=H9B�G=B8�9=B;9F=7<H9H�=B�89B9B��#,-'9@8IB;9B�695F69=H9H�K9F89B�
�#,-'9@8IB;9B�IB8��9<5B8@IB;GNK=G7<9B:Q@@9�K9F89B�8IF7<�9=B9�GMGH9A=G7<9� 9<@9F5B5@MG9�695F69=H9H�
Bem
erk
un
gen
�=9��@=9B=5*F=J5H?@=B=?;FIDD9�69HF9=6H�9=B�;FIDD9BK9=H9G�%IB89B'9@89,9?@5A5H=CBG�#,-�*CFH5@���#,-�'9@8IB;9B�K9F89B�HF=5;=9FH�IB8�8IF7<�8=9
69HFC::9B9B�0CF;9G9HNH9B�69<5B89@H�IB8�'5GGB5<A9B�89:=B=9FH���=B9�P69FG=7<H�89F��#,-� Q@@9�IB8�89F9B�%5H9;CF=9B�K=F8�>Q<F@=7<�89F�!FIDD9B@9=HIB;�IB8
89A�09FK5@HIB;GF5H�JCF;9GH9@@H�IB8�:@=9GGH�=BG�,=G=?CA5B5;9A9BH�9=B���B89�� ���KIF89�85G�%',��#,-�%CBN9DH�T69F5F69=H9H�IB8�5?HI5@=G=9FH��#A�'QFN
� ��K=F8�8=9�@=9B5�-7<@SGG@=��!�=B�9=B9A�*=@CH�I8=H�8IF7<�89B�%5BHCB�3TF=7<�NIA�.<9A5��#,-�5I8=H=9FH���=9�%=B89F�IB8�$I;9B8DGM7<=5HF=989F��@=9B=5
&=HH9B<9=8��!�K=F8�85GG9@69��I8=H�=A�$I@=�� ���969B:5@@G�8IF7<@5I:9B�
+I5@=HQHG69F=7<H�� ��
�b
erb
lick �
ber
s�m
tlic
he Q
ualit�
tsakti
vit
�te
n
�@=9B=5*F=J5H?@=B=?;FIDD9
-9=H9����JCB���
Zert
ifiz
ieru
ng
s�
bers
ich
t4.5 U
nser
Betr
ieb
ist
wie
fo
lgt
zert
ifiz
iert
:
An
gew
en
dete
No
rmB
ere
ich
, d
er
mit
dem
Sta
nd
ard
/ d
er
No
rm a
rbeit
et
Jah
r d
er
ers
ten
Zert
ifiz
ieru
ng
/ A
ssessm
en
tJah
r d
er
letz
ten
Reze
rtif
izie
run
g /
Assessm
en
t
Ko
mm
en
tare
�IG=B9GG��L79@@9B79�� +'
�@=9B=5�-7<@SGG@=��!
� �
� ��
,97C;B=G98�:CF
9L79@@9B79���
�IG=B9GG��L79@@9B79�� +'
�@=9B=5�&=HH9B<9=8��!
� �
� ��
,97C;B=G98�:CF
9L79@@9B79���
��.�39FH=:=N=9FIB;
-H5H=CB����%@=B=?�-7<@SGG@=
-HF9GG:C@;99F?F5B?IB;9B�IB8
�ACH=CBGF9;I@5H=CB�A=H
�9<5B8@IB;GG7<K9FDIB?H���.
� �
� ��
��.�39FH=:=N=9FIB;
*TBH�(CF8�%@=B=?�&=HH9B<9=8
� �
� ��
-7<9A5H<9F5D=9�39FH=:=N=9FIB;
*TBH�(CF8�%@=B=?�&=HH9B<9=8
� ��
� ��
*GM7<CHF5IA5HC@C;=9
39FH=:=N=9FIB;
-H5H=CB�15@89;;���%@=B=?�&=HH9B<9=8
� ��
� ��
��.����39FH=:=N=9FIB;
3%$**�&=B89���%@=B=?�&=HH9B<9=8
� ��
� ��
�%�-�X�"���F5B7<9B@SGIB;
�@=9B=5�&=HH9B<9=8��!
� �
� ��
��JCB���*IB?H9B
�%�-�X�"���F5B7<9B@SGIB;
�@=9B=5�-7<@SGG@=��!
� �
� ��
��JCB���*IB?H9B
�I@=B5F=IA
%T7<9���!5GHFCBCA=9�&=HH9B<9=8
� �
� ��
��%FCB9B
39FH=:=N=9FIB;�*5@@=5H=J9��5F9
�9F;<9=A
� ��
� ��
3K=G7<9B9J5@I5H=CB
+I5@=?=H5���*FC�9FH
%=B89FH5;9GGHQHH9�&=HH9B<9=8
� ��
� ��
+/�&�����#-)��� �
&56CF�%@=B=?9B
����
� ��
+I5@=HQHG69F=7<H�� ��
�b
erb
lick �
ber
s�m
tlic
he Q
ualit�
tsakti
vit
�te
n
�@=9B=5*F=J5H?@=B=?;FIDD9
-9=H9����JCB���
QUALIT�TSMESSUNGEN
Befragungen
Patientenzufriedenheit5/A:5GG9B89�*5H=9BH9B69:F5;IB;9B�GH9@@9B�9=B�K=7<H=;9G��@9A9BH�89G�+I5@=HQHGA5B5;9A9BHG�85F�85G=9�,T7?A9@8IB;9B�NIF�3I:F=989B<9=H�89F�*5H=9BH9B�IB8��BF9;IB;9B�:TF�09F69GG9FIB;GDCH9BH=5@9;969B�
Eigene Befragung5.1
3T*5N�IB8�'TD:�����
�=9�%@=B=?�-7<@SGG@=�:T<FH�9=B9��5I9FA9GGIB;�89F�3I:F=989B<9=H�89F�GH5H=CBQF9B�*5H=9BH9B�A=H�89A3T*5N�8IF7<���=9�%@=B=?�&=HH9B<9=8�:T<FH�5@@9���$5<F9�9=B9�'9GGIB;�89F�3I:F=989B<9=H�89F�GH5H=CBQF9B*5H=9BH9B�A=H�89A�'TD:���8IF7<��-QAH@=7<9�5A6I@5BH9B�-H5B8CFH9�89F�!FIDD9�<569B�=A�� ���9=B93I:F=989B<9=HGA9GGIB;�89F�*5H=9BH9B�A=H�89A�'T* �5A6I@5BH�8IF7<;9:T<FH���=9��F;96B=GG9�G=B88IF7<;9<9B8�;IH���9BBC7<�KIF89B�8=9��F;96B=GG9G�IB8�8=9�C::9B9B�%CAA9BH5F9�;9B5I�5B5@MG=9FHIB8�'5GGB5<A9B�56;9@9=H9H�� C@;9B89�-7<K9FDIB?H9�?CBBH9B�9F?5BBH�K9F89B�
] 09F:T;65F?9=H�5I7<�=B�%F=G9B�C89F�(CH:Q@@9B] @9L=6@9�.9FA=BD@5BIB;] 57<?CAD9H9BN] !IH�NI<SF9B�?SBB9B] �I:�8=9�=B8=J=8I9@@9B��98TF:B=GG9�9=B;9<9B�IB8�<=@:F9=7<9�.=DDG�;969B] '=HGDF57<9�IB8�19FHG7<QHNIB;
�=9G9 *5H=9BH9B69:F5;IB; <569B�K=F�=A�'CB5H�$IB=�=B�89B��6H9=@IB;9B�\*GM7<=5HF=9N9BHF9B�19HN=?CB/GH9F�'QBB98CF:Z�\*GM7<=5HF=9N9BHFIA� F5I9B:9@8�IB8�-=FB57<Z�\!FIDD9BDF5L9B�1=BH9FH<IF)9F@=?CB��=9H=?CBZ�8IF7<;9:T<FH��9:F5;H�KIF89B�5@@9�5AI@5BH9B�*5H=9BH9B�A=H�A=B8����%CBGI@H5H=CB���IG;9G7<@CGG9B�KIF89B�*5H=9BH9B89F�.5;9G?@=B=?9B�
�66��!9G5ANI:F=989B<9=H�89F�5A6I@5BH9B�*5H=9BH9B�DFC�-H5B8CFH
Angaben zur Messung
�IGK9FHIB;G=BGH=HIH /*%
'9H<C89���#BGHFIA9BH 'T* ����
Beschwerdemanagement5.2
/BG9F��9HF=96�<5H�9=B��9G7<K9F89A5B5;9A9BH���9=B9�)A6I8GGH9@@9�
+I5@=HQHG69F=7<H�� �� Patientenzufriedenheit
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9����JCB���
Mitarbeiterzufriedenheit6�=9�'9GGIB;�89F�'=H5F69=H9FNI:F=989B<9=H�@=9:9FH�89B��9HF=969B�K9FHJC@@9�#B:CFA5H=CB9B�K=9�8=9'=H5F69=H9F�85G�-D=H5@�5@G��F69=H;969F�IB8�=<F9��F69=HGG=HI5H=CB�9AD:IB89B�<569B�
Eigene Befragung6.1
=7CAA=H�����
�=9��@=9B=5�:T<FH�5@@9���$5<F9�9=B9�IA:5B;F9=7<9��9:F5;IB;�=<F9F�'=H5F69=H9B89B�8IF7<��#A�� ���KIF89NIA�9FGH9B�'5@�8=9�'9GGIB;�A=H�=7CAA=H�8IF7<;9:T<FH�IA�69GG9F9��9B7<A5F?�'S;@=7<?9=H9B�NIBIHN9B���@=9B=5�?5BB�G9<F�;IH9�3I:F=989B<9=HGK9FH9�5IGK9=G9B���9=�89F��9K9FHIB;�89F��HHF5?H=J=HQH�89G�F69=H;969FG�;969B�8=9�'=H5F69=H9B89B����JCB�� �AS;@=7<9B�*IB?H9B�5B��� ��89F�'=H5F69=H9B89B9AD:9<@9B�8=9��@=9B=5�A=H�<C<9F�3IGH=AAIB;�5@G��F69=HG;969F�K9=H9F�IB8�����A=H�A=HH@9F9F3IGH=AAIB;���=9G�6989IH9H�85GG�BIF����89F�'=H5F69=H9B89B�8=9��F69=H;969F=B�B=7<H�K9=H9F9AD:9<@9B�
�=9G9 '=H5F69=H9F69:F5;IB; <569B�K=F�=A�'CB5H�$IB=�=B�5@@9B��6H9=@IB;9B�8IF7<;9:T<FH��G�KIF89B�GQAH@=7<9�'=H5F69=H9B89B�69:F5;H�
�66��*9FGSB@=7<9��=BGH9@@IB;9B�89F�'=H5F69=H9B89B�89F��@=9B=5*F=J5H?@=B=?;FIDD9
Angaben zur Messung
�IGK9FHIB;G=BGH=HIH =7CAA=H
'9H<C89���#BGHFIA9BH =7CAA=H
+I5@=HQHG69F=7<H�� �� Mitarbeiterzufriedenheit
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9����JCB���
Zuweiserzufriedenheit7�9=�89F�-D=H5@K5<@�GD=9@9B�9LH9FB9�3IK9=G9B89��"5IGQFNH9�B=989F;9@5GG9B9�-D9N=5@QFNH9��9=B9K=7<H=;9�,C@@9��0=9@9�*5H=9BH9B�@5GG9B�G=7<�=B�89A�-D=H5@�69<5B89@B�85G�=<B9B�=<F��FNH�9AD:C<@9B�<5H��=9�'9GGIB;�89F�3IK9=G9FNI:F=989B<9=H�@=9:9FH�89B��9HF=969B�K9FHJC@@9�#B:CFA5H=CB9B�K=9�8=93IK9=G9F�89B��9HF=96�IB8�8=9�:57<@=7<9��9HF9IIB;�89F�NI;9K=9G9B9B�*5H=9BH9B�9AD:IB89B�<569B�
Eigene Befragung7.1
�=;9B9��9:F5;IB;�����
#A�$5<F9�� ���KIF89�?9=B9��9:F5;IB;�89F�3IK9=G9B89B 8IF7<;9:T<FH�
�=9G9 3IK9=G9F69:F5;IB; <569B�K=F�=A�$5<F�� ���=B�5@@9B��6H9=@IB;9B�8IF7<;9:T<FH�
Angaben zur Messung
�9HF=96G=BH9FB�9BHK=7?9@H9�'9H<C89���#BGHFIA9BH
+I5@=HQHG69F=7<H�� �� Zuweiserzufriedenheit
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9����JCB���
Behandlungsqualit�t
Freiheitsbeschr�nkende Massnahmen8
Nationale Erfassung der freiheitsbeschr�nkenden Massnahmen in derErwachsenenpsychiatrie und Kinder- und Jugendpsychiatrie
8.1
�9F�� '���F:5GGIB;� F9=<9=HG69G7<FQB?9B89F�'5GGB5<A9B��9F:5GGH�5@G�'=B89GH85H9BG5HN�89B�9H<=G7<G9<F�G9BG=6@9B�IB8�A=H�;FSGGH9F�-CF;:5@H�NI�69<5B89@B89B��=BG5HN�JCB�:F9=<9=HG69G7<FQB?9B89B'5GGB5<A9B���=9G9�GC@@H9B�G9@H9B�IB8�BIF�;IH�69;FTB89H�IB8�J�5��IBH9F�NK=B;9B89F��957<HIB;�89FB5H=CB5@9B�IB8�?5BHCB5@9B�;9G9HN@=7<9B��9GH=AAIB;9B�9=B;9G9HNH�K9F89B���F:5GGH�K9F89B�JCB�89B 5@@:T<F9B89B�69=��BK9B8IB;�#GC@5H=CB9B� =L=9FIB;9B�IB8�3K5B;GA98=?5H=CB9B�GCK=9-=7<9F<9=HGA5GGB5<A9B�=A�-HI<@�IB8�=A��9HH�K=9�N����-H97?6F9HH9F�JCF�89A�-HI<@��9HH;=HH9F�3�1#�97?9B�
19=H9F:T<F9B89�#B:CFA5H=CB9B� KKK�5BE�7<�DGM7<=5HF=9
Messergebnisse�5�8=9��(+'9GGIB;9B�:TF�-D=H5@�IB8�%@=B=?J9F;@9=7<9�?CBN=D=9FH�KIF89B�G=B8�8=9�GD=H5@�6NK�?@=B=?GD9N=:=G7<9B��F;96B=GG9�BIF�698=B;H�5IGG5;9?FQ:H=;���9F��(+�DI6@=N=9FH�8=9�'9GG9F;96B=GG9�=BJ9F;@9=7<9B89F��5FGH9@@IB;�5I:�G9=B9F�196G=H9 KKK�5BE�7<�
Kommentar zur Entwicklung der Messergebnisse, Pr�ventionsmassnahmen und / oderQualit�tsaktivit�ten
�=9��F;96B=GG9�K9F89B�8IF7<��(+�J9FS::9BH@=7<H�
Angaben zur Messung
�IGK9FHIB;G=BGH=HIH /B=J9FG=HQF9�*GM7<=5HF=G7<9�%@=B=?9B��/*%���5G9@
'9H<C89���#BGHFIA9BH � '
+I5@=HQHG69F=7<H�� �� Freiheitsbeschr�nkende Massnahmen
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9����JCB���
Psychische Symptombelastung9
Nationale Messung in der Erwachsenenpsychiatrie9.1
�=9��(+�'9GGJCF;569B�=B�89F��FK57<G9B9BDGM7<=5HF=9�;9@H9B�G9=H�$I@=�� ���:TF�5@@9��9F9=7<9�89FGH5H=CBQF9B�09FGCF;IB;��=B?@��DGM7<=5HF=G7<9F��6H9=@IB;9B�9=B9G�5?IHGCA5H=G7<9B�-D=H5@G*GM7<CGCA5H=?�GD9N=5@=G=9FH9�-I7<H?@=B=?9B�IB8��@H9FGDGM7<=5HF=9��B=7<H�>98C7<�:TF�.5;9G?@=B=?9B�IB85A6I@5BH9��B;96CH9�
�9=�5@@9B�*5H=9BH9B�=B�89F�*GM7<=5HF=9�K=F8�8=9�-MADHCA69@5GHIB;���BN5<@�IB8�-7<K9F9;F58JCF<5B89B9F�-MADHCA9�9=B9F�DGM7<=G7<9B�-HSFIB;��69=��=B�IB8��IGHF=HH�9F:5GGH���5G�9<5B8@IB;G9F;96B=G�K=F8�5BG7<@=9GG9B8�5@G�09FQB89FIB;�89F�-MADHCA69@5GHIB;��5@G��9@H5NK=G7<9B��=B�IB8��IGHF=HH��5IG;9K9FH9H�
�=9� 5@@:T<F9B89B�K=9�5I7<�8=9�*5H=9BH9B�69IFH9=@9B�8=9�-MADHCA69@5GHIB;�69=��=B�IB8��IGHF=HH�A=H�>99=B9A�85:TF�69GH=AAH9B� F5;96C;9B�
"C()-��8I@HG��"95@H<�C:�H<9�(5H=CB�)IH7CA9�-75@9G��A=GGH�8=9�09FQB89FIB;�89F�-MADHCA69@5GHIB;9=B9G�*5H=9BH9B�A=HH9@G���� F5;9#H9AG���=9��F<96IB;�65G=9FH�5I:�89F��=BG7<QHNIB;�89F� 5@@:T<F9B89B� F9A869K9FHIB;��
�-�&���F=9:�-MADHCA��<97?@=GH��A=GGH�8=9�09FQB89FIB;�89F�-MADHCA69@5GHIB;�9=B9G�*5H=9BH9BA=HH9@G���� F5;9#H9AG���=9��F<96IB;�65G=9FH�5I:�89F��=;9BG=7<H�IB8�-9@6GHK5<FB9<AIB;�89F*5H=9BH9B��-9@6GH69K9FHIB;��
19=H9F:T<F9B89�#B:CFA5H=CB9B� KKK�5BE�7<�DGM7<=5HF=9
Messergebnisse
HoNOS Adults � �� � �� � �� � ��
Clienia-Privatklinikgruppe
"C()-��8I@HG��9<5B8@IB;G9F;96B=G�'=HH9@K9FH�89F�09FQB89FIB;�JCB��=BHF=HH�NI��IGHF=HH�
�� ��� ��� ���
-H5B85F856K9=7<IB;����� �
19FHIB;�89F��F;96B=GG9�����*IB?H9���A5L=A5@�AS;@=7<9�09FG7<@97<H9FIB;������*IB?H9���A5L=A5@�AS;@=7<9�09F69GG9FIB;
BSCL � �� � �� � �� � ��
Clienia-Privatklinikgruppe
�-�&��9<5B8@IB;G9F;96B=G�'=HH9@K9FH�89F�09FQB89FIB;�JCB��=BHF=HH�NI��IGHF=HH�
��� ���� � �� ����
-H5B85F856K9=7<IB;����� �
19FHIB;�89F��F;96B=GG9������*IB?H9���A5L=A5@�AS;@=7<9�09FG7<@97<H9FIB;�������*IB?H9���A5L=A5@�AS;@=7<9�09F69GG9FIB;
�5�8=9��(+'9GGIB;9B�:TF�-D=H5@�IB8�%@=B=?J9F;@9=7<9�?CBN=D=9FH�KIF89B�G=B8�8=9�GD=H5@�6NK�?@=B=?GD9N=:=G7<9B��F;96B=GG9�BIF�698=B;H�5IGG5;9?FQ:H=;���9F��(+�DI6@=N=9FH�8=9�'9GG9F;96B=GG9�=BJ9F;@9=7<9B89F��5FGH9@@IB;�5I:�G9=B9F�196G=H9 KKK�5BE�7<�
+I5@=HQHG69F=7<H�� �� Psychische Symptombelastung
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9����JCB���
Kommentar zur Entwicklung der Messergebnisse, Pr�ventionsmassnahmen und / oderQualit�tsaktivit�ten
�9H5=@@=9FH9F9��F;96B=GG9�:TF�85G�� ���?SBB9B�=A��(+��9F=7<H�;9:IB89B�K9F89B� �=9�<=9F�85F;9GH9@@H9B��5H9BG=B8�B=7<H�F=G=?C58>IGH=9FH���5G =BH9FB9��CBHFC@@=B; 5F69=H9H�A=H B=7<HF=G=?C58>IGH=9FH9B��5H9B�6=G�8=9�IGK9FHIB;9B�5B��(+�J9FS::9BH@=7<H�K9F89B���IF7<�8=9G9�0CF;9<9BGK9=G9�G=B8�N9=HB5<9�'5GGB5<A9BAS;@=7<�
Angaben zur Messung
�IGK9FHIB;G=BGH=HIH /B=J9FG=HQF9�*GM7<=5HF=G7<9�%@=B=?9B��/*%���5G9@
'9H<C89���#BGHFIA9BH "C()-��8I@HG��"95@H<�C:�H<9�(5H=CB�)IH7CA9�-75@9G��IB8�-�&���F=9:�-MADHCA��<97?@=GH�
Angaben zum untersuchten Kollektiv
�=BG7<@IGG?F=H9F=9B �@@9�GH5H=CBQF9B�*5H=9BH9B�89F��FK57<G9B9BDGM7<=5HF=9�0C@@9F<96IB;�
!9G5AH<9=H�89F�NIIBH9FGI7<9B89B*5H=9BH9B �IGG7<@IGG?F=H9F=9B *5H=9BH9B�89F�%=B89F�IB8�$I;9B8DGM7<=5HF=9
Nationale Messung in der Kinder- und Jugendpsychiatrie9.2
�=9��(+�'9GGJCF;569B�=B�89F�%=B89F�IB8�$I;9B8DGM7<=5HF=9�;9@H9B�G9=H�$I@=�� ���:TF�5@@9��9F9=7<989F�GH5H=CBQF9B�09FGCF;IB;��=B?@��DGM7<=5HF=G7<9F��6H9=@IB;9B�9=B9G�5?IHGCA5H=G7<9B�-D=H5@G*GM7<CGCA5H=?�GD9N=5@=G=9FH9�-I7<H?@=B=?9B��B=7<H�>98C7<�:TF�.5;9G?@=B=?9B�IB8�5A6I@5BH9��B;96CH9�
�9=�5@@9B�*5H=9BH9B�=B�89F�*GM7<=5HF=9�K=F8�8=9�-MADHCA69@5GHIB;���BN5<@�IB8�-7<K9F9;F58JCF<5B89B9F�-MADHCA9�9=B9F�DGM7<=G7<9B�-HSFIB;��69=��=B�IB8��IGHF=HH�9F:5GGH���5G�9<5B8@IB;G9F;96B=G�K=F8�5BG7<@=9GG9B8�5@G�09FQB89FIB;�89F�-MADHCA69@5GHIB;��5@G��9@H5NK=G7<9B��=B�IB8��IGHF=HH��5IG;9K9FH9H�
�=9� 5@@:T<F9B89B�K=9�5I7<�8=9�*5H=9BH9B�69IFH9=@9B�8=9�-MADHCA69@5GHIB;�69=��=B�IB8��IGHF=HH�A=H�>99=B9A�85:TF�69GH=AAH9B� F5;96C;9B�
"C()-����"95@H<�C:�H<9�(5H=CB�)IH7CA9�-75@9G�:CF��<=@8F9B�5B8��8C@9G79BHG��A=GGH�8=909FQB89FIB;�89F�-MADHCA69@5GHIB;�9=B9G�*5H=9BH9B�A=HH9@G���� F5;9#H9AG���=9��F<96IB;�65G=9FH5I:�89F��=BG7<QHNIB;�89F� 5@@:T<F9B89B�� F9A869K9FHIB;��
"C()-��-,��"95@H<�C:�H<9�(5H=CB�)IH7CA9�-75@9G�:CF��<=@8F9B�5B8��8C@9G79BHG�-9@:�,5H=B;��A=GGH8=9�09FQB89FIB;�89F�-MADHCA69@5GHIB;�9=B9G�*5H=9BH9B�A=HH9@G���� F5;9#H9AG���=9��F<96IB;�65G=9FH5I:�89F��=;9BG=7<H�IB8�-9@6GHK5<FB9<AIB;�89F�*5H=9BH9B��-9@6GH69K9FHIB;��
Messergebnisse�5�8=9��(+'9GGIB;9B�:TF�-D=H5@�IB8�%@=B=?J9F;@9=7<9�?CBN=D=9FH�KIF89B�G=B8�8=9�GD=H5@�6NK�?@=B=?GD9N=:=G7<9B��F;96B=GG9�BIF�698=B;H�5IGG5;9?FQ:H=;���9F��(+�DI6@=N=9FH�8=9�'9GG9F;96B=GG9�=BJ9F;@9=7<9B89F��5FGH9@@IB;�5I:�G9=B9F�196G=H9 KKK�5BE�7<�
/BG9F��9HF=96�J9FN=7<H9H�5I:�8=9�*I6@=?5H=CB�89F�'9GG9F;96B=GG9�=B�8=9G9A�+I5@=HQHG69F=7<H�
Begr�ndung�=9��F;96B=GG9�K9F89B�JCB��(+�J9FS::9BH@=7<H�K9F89B�
Angaben zur Messung
�IGK9FHIB;G=BGH=HIH /B=J9FG=HQF9�*GM7<=5HF=G7<9�%@=B=?9B��/*%���5G9@
'9H<C89���#BGHFIA9BH "C()-����"95@H<�C:�H<9�(5H=CB�)IH7CA9�-75@9G�:CF�<=@8F9B�5B8��8C@9G79BHG��IB8�"C()-��-,��"95@H<�C:H<9�(5H=CB�)IH7CA9�-75@9G�:CF��<=@8F9B�5B8��8C@9G79BHG-9@:�,5H=B;�
+I5@=HQHG69F=7<H�� �� Psychische Symptombelastung
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9�� �JCB���
Projekte im Detail10#B�8=9G9A�%5D=H9@�?SBB9B�-=9�G=7<�T69F�8=9�K=7<H=;GH9B�+I5@=H5HGDFC>9?H9�=B:CFA=9F9B�
Aktuelle Qualit�tsprojekte10.1
�#,-��I8=H� ����
�9F�%5BHCB�3TF=7<�:T<FH�9=B��I8=H�T69F�85G��#,-�89F�%@=B=?9B�A=H�9=B9A�&9=GHIB;G5I:HF5;�8IF7<���=9%@=B=?�-7<@SGG@=�<5H�G=7<�5@G�*=@CH?@=B=?�;9A9@89H�8=9�%=B89F�IB8�$I;9B8DGM7<=5HF=9�89F�%@=B=?&=HH9B<9=8�K9F89B�GDQH9F�969B:5@@G�5I8=H=9FH�
Abgeschlossene Qualit�tsprojekte im Berichtsjahr 201510.2
�=J9FG9G� ����
�=9��@=9B=5�*F=J5H?@=B=?;FIDD9�:T<FH9�9=B=;9�*FC>9?H9�8IF7<�K9@7<9�8=9�+I5@=HQH�8=F9?H�C89F�=B8=F9?H699=B:@IGG9B���=9��?H=J=HQH9B�?SBB9B�=A�$5<F9G69F=7<H�� �� B57<;9@9G9B�K9F89B�
Aktuelle Zertifizierungsprojekte10.3
F9A85GG9GGA9BH�,���%@=B=?�-7<@SGG@=�IB8�&=HH9B<9=8� ����
�9=89�%@=B=?9B�K9F89B�=A����+I5FH5@�89G�� ���9=B�K9=H9F9G� F9A85GG9GGA9BH�8IF7<:T<F9B�
+I5@=HQHG69F=7<H�� �� Projekte im Detail
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9����JCB���
Schlusswort und Ausblick11�G�=GH�IBG�9=B�;FCGG9G��B@=9;9B�IBG9F9�+I5@=HQH�=BG69GCB89F9�;9;9BT69F�89B�*5H=9BH9B�K9=H9F�NIGH9=;9FB���@G�!FIDD9�@=9;H�8569=�K9=H9F<=B�IBG9F�-7<K9FDIB?H�5I:�89A�(IHN9B�89F�;FIDD9B=BH9FB9B-MB9F;=9B�569F�5I7<�IBG9F9F�9LH9FB9B�(9HNK9F?9��1=F�BIHN9B�=BH9FB9�IB8�9LH9FB909F;@9=7<GAS;@=7<?9=H9B�IA�NI�@9FB9B�IB8�IBG�NI�J9F69GG9FB�
+I5@=HQHG69F=7<H�� �� Schlusswort und Ausblick
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9����JCB���
Anhang 1: �berblick �ber das betriebliche Angebot�=9��B;569B�NIF�-HFI?HIF�IB8�NI�89B�&9=GHIB;9B�89G�-D=H5@G�J9FA=HH9@B�9=B9B �berblick T69F�85G69HF=96@=7<9��B;96CH���5G�69HF=96@=7<9��B;96CH�65G=9FH�5I:�89F�5?HI9@@GH9B�'98=N=B=G7<9B�-H5H=GH=?�89G�IB89G5AHG�:TF�-H5H=GH=?���=9G9��B;569B�69N=9<9B�G=7<�BIF�5I:�GH5H=CBQF�69<5B89@H9�*5H=9BH9B�
3IGQHN@=7<9�#B:CFA5H=CB9B�NIA�69HF=96@=7<9B��B;96CH�:=B89B�-=9�=A�-D=H5@�IB8�%@=B=?*CFH5@GD=H5@=B:CFA5H=CB�7< IB8�=A�5?HI9@@9B�$5<F9G69F=7<H�
Psychiatrie
&9=GHIB;G5B;96CH�=B�89F�*GM7<=5HF=9
ICD-Nr. Angebot nach Hauptaustrittsdiagnose
F0 )F;5B=G7<9�9=BG7<@=9GG@=7<�GMADHCA5H=G7<9F�DGM7<=G7<9F�-HSFIB;9B
F1 *GM7<=G7<9�IB8�09F<5@H9BGGHSFIB;9B�8IF7<�DGM7<CHFCD9�-I6GH5BN9B
F2 -7<=NCD<F9B=9�G7<=NCHMD9�IB8�K5<B<5:H9�-HSFIB;9B
F3 �::9?H=J9�-HSFIB;9B
F4 (9IFCH=G7<9��9@5GHIB;G�IB8�GCA5HC:CFA9�-HSFIB;9B
F5 09F<5@H9BG5I::Q@@=;?9=H9B�A=H�?SFD9F@=7<9B�-HSFIB;9B�IB8� 5?HCF9B
F6 *9FGSB@=7<?9=HG�IB8�09F<5@H9BGGHSFIB;9B
F7 #BH9@@=;9BNGHSFIB;9B
F8 �BHK=7?@IB;GGHSFIB;9B
F9 09F<5@H9BG�IB8�9ACH=CB5@9�-HSFIB;9B�A=H��9;=BB�=B�89F�%=B8<9=H�IB8�$I;9B8
Bemerkungen�=9��@=9B=5*F=J5H?@=B=?;FIDD9�6=9H9H�5B�=<F9B�J9FG7<=989B9B�-H5B8CFH9B :TF�5@@9��@H9FG?@5GG9B�9<5B8@IB;�:TF�GQAH@=7<9��=5;BCG9B;FIDD9B �� ��5B���=9G�69=B<5@H9H�5A6I@5BH9�H5;9G?@=B=G7<9GH5H=CBQF9�IB8�&5B;N9=H �B;96CH9��=9��@=9B=5�<5H�&9=GHIB;GJ9FHFQ;9�A=H�FIB8����%5BHCB9B�
�=9G9�IA:5B;F9=7<9��B;96CH�9BHGDF=7<H�IBG9F9F Mission�#A�39BHFIA�IBG9F9G�.IBG�GH9<H�8=9�:57<?IB8=;9�9F:C@;F9=7<9��9<5B8@IB;�IBG9F9F�*5H=9BH9B��1=F6=9H9B�:TF�85G�;5BN9�-D9?HFIA�DGM7<=G7<9F��F?F5B?IB;9B�5I:�=B8=J=8I9@@9��98TF:B=GG9�56;9GH=AAH9�=5;BCGH=?��9<5B8@IB;�IB8�.<9F5D=9�JCB�<S7<GH9F�+I5@=HQH���569=�@9=GH9B�K=F�9=B9B�K9G9BH@=7<9B�9=HF5;�NIF��F:T@@IB;�89F�DGM7<=5HF=G7<9B�!9GIB8<9=HGJ9FGCF;IB;�
19=H9F9��B;569B�:=B89B�-=9�=A�$5<F9G69F=7<H�IB8�5I:�89F 196G9=H9�KKK�7@=9B=5�7<
�
+I5@=HQHG69F=7<H�� �� Anhang 1: �berblick �ber das betriebliche Angebot
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9����JCB���
Herausgeber
�=9�0CF@5;9�:TF�8=9G9B�+I5@=HQHG69F=7<H�K=F8�JCB�"��<9F5IG;969B�"���=9�-D=HQ@9F�89F�-7<K9=N&CFF5=B9GHF5GG9����� ����9FB
-=9<9�5I7<�KKK�<D@IG�7<�89�8=9BGH@9=GHIB;9B�EI5@=H59H4D5H=9BH9BG=7<9F<9=H�EI5@=H59HG69F=7<H
�=9�=A��9F=7<H�J9FK9B89H9B�-MA6C@9�:TF�8=9�-D=H5@?5H9;CF=9B��?IHGCA5H=?�*GM7<=5HF=9IB8�,9<56=@=H5H=CB�GH9<9B�BIF�8CFH�KC�'C8I@9�9=BN9@B9�%5H9;CF=9B�69HF9::9B�
Beteiligte Gremien und Partner
�=9�0CF@5;9�:TF�89B�+I5@=HQHG69F=7<H�KIF89�=B�3IG5AA9B5F69=H�A=H�89F-H9I9FIB;G;FIDD9�JCB QABE �+I5@=HQHG9BHK=7?@IB;�=B�89F��?IHJ9FGCF;IB;�69=-D=HQ@9FB�=A�%5BHCB��9FB��9F5F69=H9H�
�=9�0CF@5;9�K=F8�@5I:9B8�=B�3IG5AA9B5F69=H�A=H�89F�"�� 57<?CAA=GG=CB�+I5@=HQH�?IHGCA5H=?��FKQA��9=BN9@B9B�%5BHCB9B�IB8�5I:��BHFQ;9�JCB�&9=GHIB;G9F6F=B;9FB�<=BK9=H9F9BHK=7?9@H�-=9<9�5I7<�KKK�<D@IG�7<�89�G9FJ=79B5J�I969F4IBG�:57<?CAA=GG=CB9B�EI5@=H59H45?IHGCA5H=?4:?E5
�=9�-7<K9=N9F=G7<9�%CB:9F9BN�89F�?5BHCB5@9B�!9GIB8<9=HG8=F9?HCF=BB9B�IB8�8=F9?HCF9B��GDK��9AD:=9<@H�89B�%5BHCB9B�8=9�-D=HQ@9F�NIF��9F=7<H9FGH5HHIB;�T69F�8=9�9<5B8@IB;GEI5@=HQH�NI�J9FD:@=7<H9B�IB8�=<B9B�8=9�09FK9B8IB;�89F�"��9F=7<HGJCF@5;9IB8�8=9�*I6@=?5H=CB�89G��9F=7<HG�5I:�89F�"�*@5HH:CFA KKK�GD=H5@=B:CFA5H=CB�7< B5<9NI�@9;9B�
�=9�0CF@5;9�:TF�89B�+I5@=HQHG69F=7<H�GHTHNH�G=7<�5I:�8=9��AD:9<@IB;9B���F<96IB;�B5@MG9�IB8�09FS::9BH@=7<IB;�JCB��5H9B�T69F�8=9�A98=N=B=G7<9��9<5B8@IB;GEI5@=HQH�89F�-7<K9=N9F=G7<9B��?589A=9�89F�'98=N=B=G7<9B�1=GG9BG7<5:H��SAMW��
�=9 Stiftung Patientensicherheit Schweiz =GH�9=B9�B5H=CB5@9�*@5HH:CFA�NIF��BHK=7?@IB;IB8� SF89FIB;�89F�*5H=9BH9BG=7<9F<9=H��-=9�5F69=H9H�=B�(9HNK9F?9B�IB8�%CCD9F5H=CB9B��569=�;9<H�9G�IA�85G�&9FB9B�5IG� 9<@9FB�IB8�85G� SF89FB�89F�-=7<9F<9=HG?I@HIF�=B!9GIB8<9=HG=BGH=HIH=CB9B���5:TF�5F69=H9H�8=9�-H=:HIB;�D5FHB9FG7<5:H@=7<�IB8�?CBGHFI?H=JA=H��?H9IF9B�=A�!9GIB8<9=HGK9G9B�NIG5AA9B�-=9<9�5I7<� KKK�D5H=9BH9BG=7<9F<9=H�7<
�9F�(5H=CB5@9�09F9=B�:TF�+I5@=HQHG9BHK=7?@IB;�=B�-D=HQ@9FB�IB8�%@=B=?9B��ANQ�?CCF8=B=9FH�IB8�F95@=G=9FH�+I5@=HQHGA9GGIB;9B�=B�89F��?IHGCA5H=?�89F�,9<56=@=H5H=CBIB8�89F�*GM7<=5HF=9�-=9<9�5I7<� KKK�5BE�7<
+I5@=HQHG69F=7<H�� �� Herausgeber
�@=9B=5*F=J5H?@=B=?;FIDD9 -9=H9����JCB���